![SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics](https://adbio.partners/wp-content/uploads/2021/11/Groupe-288@2x-886x675.png)
![SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics](https://adbio.partners/wp-content/uploads/2021/11/Groupe-288@2x-886x675.png)
![Tenpoint Therapeutics Launches with $70 Million Series A Financing](https://adbio.partners/wp-content/uploads/2021/11/Groupe-280@2x-886x675.png)
Tenpoint Therapeutics Launches with $70 Million Series A Financing
![Astraveus raises €16.5 Million Series Seed round to advance the development of its automated, microfluidic Cell and Gene Therapy manufacturing platform](https://adbio.partners/wp-content/uploads/2021/11/Groupe-281@2x-886x675.png)
Astraveus raises €16.5 Million Series Seed round to advance the development of its automated, microfluidic Cell and Gene Therapy manufacturing platform
![Tenpoint Therapeutics Launches with $70 Million Series A Financing](https://adbio.partners/wp-content/uploads/2021/11/Groupe-280@2x-886x675.png)
Anoat Therapeutics raises €2M in seed funding to develop novel therapies for Cystic Fibrosis patients with high unmet medical need
![SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics](https://adbio.partners/wp-content/uploads/2021/11/Groupe-288@2x-886x675.png)